HEALTH.2012.2.4.3-1
HEALTH.2012.2.4.3-1
5 projects · €26,324,784 total EU contribution (project-level) · 39 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€26,324,784
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (9)
- UK (7)
- Germany (4)
- Netherlands (4)
- AT (3)
- IE (3)
- DK (2)
- BE (1)
- IL (1)
- LU (1)
- PT (1)
- SE (1)
- TR (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Leiden University Medical Center2 projects · NL
- MEDICAL UNIVERSITY OF GRAZ2 projects · AT
- PROFIL INSTITUT FUR STOFFWECHSELFORSCHUNG GMBH2 projects · DE
- AMC1 projects · NL
- AKIRA1 projects · FR
- ACS1 projects · UK
- BIONANONET FORSCHUNGSGESELLSCHAFT MBH1 projects · AT
- CARDIFF UNIVERSITY1 projects · UK
- CEED1 projects · FR
- CHL1 projects · LU
- CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER1 projects · FR
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Single-Port Insulin Infusion for Improved Diabetes Management SPIDIMAN · 305343 | FP7 | €4,941,739 | €6,372,167 | Details |
A bioartificial pancreas to treat type 1 diabetes: optimization of cell survival and function in preclinical and clinical phases BIOSID · 305746 | FP7 | €5,169,503 | €6,793,606 | Details |
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems EE-ASI · 305305 | FP7 | €5,983,871 | €7,809,429 | Details |
Repair of Diabetic Damage by Stromal Cell Administration REDDSTAR · 305736 | FP7 | €5,894,387 | €8,190,281 | Details |
A Portable bihormonal Closed Loop for Diabetes PCDIAB · 305654 | FP7 | €4,335,284 | €5,465,086 | Details |